2001 Journal Article New perspectives on the role of aldosterone excess in cardiovascular diseaseStowasser, M (2001). New perspectives on the role of aldosterone excess in cardiovascular disease. Clinical And Experimental Pharmacology And Physiology, 28 (10), 783-791. doi: 10.1046/j.1440-1681.2001.03523.x |
2001 Journal Article Primary aldosteronism: Rare bird or common cause of secondary hypertension?Stowasser, M. (2001). Primary aldosteronism: Rare bird or common cause of secondary hypertension?. Current Hypertension Reports, 3 (3), 230-239. |
2000 Journal Article Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52. |
2000 Journal Article Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasiaBofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, Richard D. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. |
2000 Journal Article Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasiaBofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, R. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. doi: 10.1038/sj.jhh.1000935 |
2000 Journal Article Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247 |
2000 Journal Article Primary aldosteronism: learning from the study of familial varietiesStowasser, M and Gordon, RD (2000). Primary aldosteronism: learning from the study of familial varieties. Journal of Hypertension, 18 (9), 1165-1176. doi: 10.1097/00004872-200018090-00002 |
2000 Journal Article A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)Lafferty, Antony R., Torpy, David J., Stowasser, Michael, Taymans, Susan E., Lin, Jing Ping, Huggard, Philip, Gordon, Richard D. and Stratakis, Constantine A. (2000). A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). Journal of Medical Genetics, 37 (11), 831-835. doi: 10.1136/jmg.37.11.831 |
2000 Journal Article Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbanceStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance. The Journal of Clinical Endocrinology and Metabolism, 85 (6), 2160-2166. doi: 10.1210/jc.85.6.2160 |
2000 Journal Article Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertensionStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension. Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jcem.85.9.6834 |
2000 Journal Article Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1pBenn, DE, Dwight, T, Richardson, AL, Delbridge, L, Bambach, CP, Stowasser, M, Gordon, RD, Marsh, DJ and Robinson, BG (2000). Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Research, 60 (24), 7048-7051. |
2000 Journal Article How common is adrenal-based mineralocortoid hypertension?Stowasser, M. (2000). How common is adrenal-based mineralocortoid hypertension?. Current Opinion in Endocrinology & Diabetes, 7 (3), 143-150. doi: 10.1097/00060793-200006000-00007 |
2000 Journal Article Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertensionStowasser, M, Bachmann, AW and Gordon, RD (2000). Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. The Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jc.85.9.3313 |
1999 Journal Article Increased severity of multifocal renal arterial fibromuscular dysplasia in smokersBofinger, A. M., Hawley, C. M., Fisher, P. M., Daunt, N., Stowasser, M. and Gordon, Richard D. (1999). Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. Journal of Human Hypertension, 13 (8), 517-520. |
1999 Journal Article Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenomaCoulter, Catherine L., Smith, Robin E., Stowasser, Michael, Sasano, Hironobu, Krozowski, Zygmunt S. and Gordon, Richard D. (1999). Expression of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma. Mollecular and Cellular endocrinology, 154 (1-2), 71-77. doi: 10.1016/S0303-7207(99)00077-5 |
1999 Journal Article Increased severity of multifocal renal arterial fibromuscular dysplasia in smokersBofinger, AM, Hawley, CM, Fisher, PM, Daunt, N, Stowasser, M and Gordon, RD (1999). Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. Journal of Human Hypertension, 13 (8), 517-520. doi: 10.1038/sj.jhh.1000873 |
1999 Journal Article Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type IStowasser, M, Huggard, PR, Rossetti, TR, Bachmann, AW and Gordon, RD (1999). Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I. Journal of Clinical Endocrinology and Metabolism, 84 (11), 4031-4036. doi: 10.1210/jc.84.11.4031 |
1998 Journal Article Expression of 11 beta HSD-2 in human adrenal cortical carcinoma and adenomaCoulter, CL, Smith, RE, Stowasser, M, Sasano, H, Krozowski, ZS and Gordon, RD (1998). Expression of 11 beta HSD-2 in human adrenal cortical carcinoma and adenoma. Endocrine Research, 24 (3-4), 875-876. |
1998 Journal Article Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) geneTorpy, DJ, Gordon, RD, Lin, JP, Huggard, PR, Taymans, SE, Stowasser, M, Chrousos, GP and Stratakis, CA (1998). Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. Journal of Clinical Endocrinology And Metabolism, 83 (9), 3214-3218. doi: 10.1210/jc.83.9.3214 |
1998 Journal Article Familial forms broaden the horizons for primary aldosteronismGordon, RD and Stowasser, M (1998). Familial forms broaden the horizons for primary aldosteronism. Trends In Endocrinology And Metabolism, 9 (6), 220-227. doi: 10.1016/S1043-2760(98)00058-7 |